Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Algorithm for the treatment of chronic depression.

M H Trivedi1, B A Kleiber

  • 1Depression and Anxiety Disorders Program, The University of Texas, Southwestern Medical Center at Dallas, 75390-9101, USA. madhukar.trivedi@utsouthwestern.edu

The Journal of Clinical Psychiatry
|April 20, 2001
PubMed
Summary

Chronic depression, a persistent mood disorder, affects 3-5% of the US population. A modified Texas Medication Algorithm Project provides a staged treatment approach for chronic depression, improving patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gender and racial/ethnic differences in physiologic responses in the Stimulant Reduction Intervention using Dosed Exercise Study.

Addictive behaviors·2020
Same author

Racial and ethnic differences in treatment outcomes among adults with stimulant use disorders after a dosed exercise intervention.

Journal of ethnicity in substance abuse·2017
Same author

Effects of depression, metabolic syndrome, and cardiorespiratory fitness on mortality: results from the Cooper Center Longitudinal Study.

Psychological medicine·2017
Same author

Toward a very brief self-report to assess the core symptoms of depression (VQIDS-SR<sub>5</sub> ).

Acta psychiatrica Scandinavica·2017
Same author

IL-1β and BDNF are associated with improvement in hypersomnia but not insomnia following exercise in major depressive disorder.

Translational psychiatry·2015
Same author

ABCB1 (MDR1) predicts remission on P-gp substrates in chronic depression.

The pharmacogenomics journal·2014

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Pharmacology

Background:

  • Chronic depression, lasting over two years, includes major depressive disorder, dysthymic disorder, double depression, and incomplete remission.
  • In the 1990s, chronic depression affected 3-5% of US adults, representing 30-35% of all depression cases.

Purpose of the Study:

  • To present a modified treatment algorithm for chronic depression.
  • To outline a staged progression of therapeutic interventions for chronic depression.

Main Methods:

  • Modification of the Texas Medication Algorithm Project for chronic depression.
  • A stepwise treatment approach beginning with monotherapy and progressing to combination therapies and other interventions.

Main Results:

Related Experiment Videos

  • The algorithm suggests initial monotherapy with selective serotonin reuptake inhibitors, nefazodone, bupropion sustained release, venlafaxine extended release, mirtazapine, or psychotherapy.
  • Later treatment stages include combination therapy, electroconvulsive therapy, atypical antipsychotics, and novel treatments.

Conclusions:

  • A comprehensive treatment algorithm can guide efficient and effective management of chronic depression.
  • This structured approach aims to improve treatment outcomes for patients with persistent depressive disorders.